Converting-enzyme inhibition and glomerular filtration rate in essential hypertension.
作者信息
Bianchi M D, Fernandes M
出版信息
N Engl J Med. 1980 Jan 17;302(3):179. doi: 10.1056/NEJM198001173020319.
PMID:6243169
Abstract
摘要
相似文献
1
Converting-enzyme inhibition and glomerular filtration rate in essential hypertension.原发性高血压中的转换酶抑制作用与肾小球滤过率
N Engl J Med. 1980 Jan 17;302(3):179. doi: 10.1056/NEJM198001173020319.
2
Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
N Engl J Med. 1979 Jul 5;301(1):9-12. doi: 10.1056/NEJM197907053010103.
3
Angiotensin-converting enzyme inhibitors.血管紧张素转换酶抑制剂
Am Fam Physician. 1980 Nov;22(5):164-5.
4
Angiotensin inhibitors for hypertension.用于治疗高血压的血管紧张素抑制剂
Compr Ther. 1980 May;6(5):14-8.
5
Renal effects of angiotensin converting enzyme inhibitors in hypertension.血管紧张素转换酶抑制剂在高血压中的肾脏效应。
Am J Med. 1986 Oct 31;81(4C):19-27. doi: 10.1016/0002-9343(86)90940-x.
6
Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.血管紧张素转换酶抑制对原发性高血压患者血压、血浆肾素活性及血浆醛固酮的影响。
J Clin Endocrinol Metab. 1978 Feb;46(2):220-6. doi: 10.1210/jcem-46-2-220.
7
Treatment of hypertension with angiotensin converting enzyme inhibitors.
Clin Exp Pharmacol Physiol Suppl. 1982;7:135-44.
8
Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?原发性高血压的肾脏保护：血管紧张素转换酶抑制剂与钙拮抗剂相比如何？
J Am Soc Nephrol. 1990 Nov;1(5 Suppl 2):S80-7.
9
[The clinical use of angiotensin converting enzyme inhibitors].[血管紧张素转换酶抑制剂的临床应用]
Duodecim. 1986;102(22):1709-16.
10
[Inhibition of the renin-angiotensin system in treating arterial hypertension].
Ter Arkh. 1982;54(11):68-70.
Zotero 插件